share_log

Taro Pharmaceutical Industries | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%), etc.

Taro Pharmaceutical Industries | SC 13D/A:超過5%持股股東披露文件(修正)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%)等

美股sec公告 ·  2022/09/08 14:54
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息